4//SEC Filing
Domzalski David 4
Accession 0001209191-24-000465
CIK 0001566044other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:17 PM ET
Size
10.0 KB
Accession
0001209191-24-000465
Insider Transaction Report
Form 4
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Stock
2024-01-01+225,000→ 496,168 total - Tax Payment
Common Stock
2024-01-02$2.28/sh−1,004$2,289→ 495,164 total - Award
Stock Option (right to buy)
2024-01-01+225,000→ 225,000 totalExercise: $2.33Exp: 2033-12-31→ Common Stock (225,000 underlying)
Footnotes (4)
- [F1]Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
- [F3]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
- [F4]The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001727794
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:17 PM ET
- Size
- 10.0 KB